Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 344 followers

Latest posts

Last updated about 4 hours ago

Cullinan, Taiho showcase 6-month survival benefit in phase 3 trial for advanced lung cancer

about 4 hours ago

Cullinan Therapeutics and Taiho Oncology unveiled phase 3 data showing survival improvements...

GE HealthCare mulls $1B imaging chemicals maker deal: Financial Times

about 17 hours ago

GE HealthCare is said to be on the cusp of buying out...

GSK’s Hansoh-partnered ADC lays down marker for lung cancer scrap with Merck

1 day ago

GSK’s risvutatug rezetecan has achieved a median overall survival of 18.5 months...

FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer

3 days ago

The FDA has delayed its approval decision for Exelixis’ oral kinase inhibitor...

The future of RAS inhibitors

3 days ago

Revolution Medicines recently made history with the approval of its RAS inhibitor...

Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?

3 days ago

The announcement from Merck & Co. and Moderna last month that their...

Singapore launches biotech-focused Boston hub to build on 'centuries-old bond'

3 days ago

Officials rubbed shoulders with business leaders in a 19th-floor meeting room to...

Chutes & Ladders—Longtime Takeda R&D chief to depart next June

3 days ago

Takeda President of Research and Development Andy Plump, M.D., Ph.D., is leaving...

Scientists boycott American Diabetes Association as fallout of June conference fracas escalates

3 days ago

Following the removal of five scientists from its annual conference in June...

In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy

3 days ago

In his first interview after taking the reins of the FDA’s Oncology...

Moving NAMs from Progress to Practice: Building the Foundation for Broader Adoption

3 days ago

The future of NAMs depends on more than innovation. Learn how sourcing...